ATE461200T1 - Inhibitoren von cysteinprotease - Google Patents

Inhibitoren von cysteinprotease

Info

Publication number
ATE461200T1
ATE461200T1 AT05702148T AT05702148T ATE461200T1 AT E461200 T1 ATE461200 T1 AT E461200T1 AT 05702148 T AT05702148 T AT 05702148T AT 05702148 T AT05702148 T AT 05702148T AT E461200 T1 ATE461200 T1 AT E461200T1
Authority
AT
Austria
Prior art keywords
protease inhibitors
cystein protease
cystein
inhibitors
protease
Prior art date
Application number
AT05702148T
Other languages
English (en)
Inventor
M Nilsson
X Zhou
L Oden
B Classon
R Noren
U Grabowska
P Jackson
P Fallon
A Carr
M Liley
M Tozer
T Johnson
V Diaz
L Crespo
J Kangasmetsa
T Bonnaud
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0400022A external-priority patent/SE0400022D0/xx
Priority claimed from SE0401332A external-priority patent/SE0401332D0/xx
Application filed by Medivir Ab filed Critical Medivir Ab
Application granted granted Critical
Publication of ATE461200T1 publication Critical patent/ATE461200T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05702148T 2004-01-08 2005-01-06 Inhibitoren von cysteinprotease ATE461200T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0400022A SE0400022D0 (sv) 2004-01-08 2004-01-08 New compounds
SE0401332A SE0401332D0 (sv) 2004-05-26 2004-05-26 New compounds
PCT/GB2005/050003 WO2005066180A1 (en) 2004-01-08 2005-01-06 Cysteine protease inhibitors

Publications (1)

Publication Number Publication Date
ATE461200T1 true ATE461200T1 (de) 2010-04-15

Family

ID=34752290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05702148T ATE461200T1 (de) 2004-01-08 2005-01-06 Inhibitoren von cysteinprotease

Country Status (12)

Country Link
US (2) US7915300B2 (de)
EP (1) EP1701960B1 (de)
JP (1) JP4787765B2 (de)
AR (1) AR047373A1 (de)
AT (1) ATE461200T1 (de)
AU (1) AU2005203972B2 (de)
BR (1) BRPI0506719A (de)
CA (1) CA2552739A1 (de)
DE (1) DE602005019971D1 (de)
ES (1) ES2341869T3 (de)
TW (1) TWI343384B (de)
WO (1) WO2005066180A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005203972B2 (en) 2004-01-08 2010-11-18 Medivir Ab Cysteine protease inhibitors
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
WO2006019831A1 (en) 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Methods for treating hepatitis c
WO2006019832A1 (en) 2004-07-22 2006-02-23 Ptc Therapeutics, Inc. Thienopyridines for treating hepatitis c
GB0513840D0 (en) * 2005-07-07 2005-08-10 Medivir Ab Cysteine protease inhibitors
GB0517279D0 (en) * 2005-08-23 2005-10-05 Amura Therapeutics Ltd Biologically active compounds
JP5222561B2 (ja) * 2005-10-07 2013-06-26 キッセイ薬品工業株式会社 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
GB0611654D0 (en) * 2006-06-13 2006-07-19 Medivir Ab Compounds
GB0614046D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614073D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614037D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614042D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614052D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614044D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614053D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0618263D0 (en) * 2006-09-18 2006-10-25 Medivir Ab Compound
WO2008114054A1 (en) * 2007-03-19 2008-09-25 Medivir Ab Protease inhibitors
WO2008149971A1 (ja) 2007-06-08 2008-12-11 Kyoto University 脳動脈瘤の治療または予防薬
US7893067B2 (en) 2007-06-27 2011-02-22 Medivir Ab Cysteine protease inhibitors
AU2008286879B2 (en) 2007-08-13 2013-08-22 Monsanto Technology Llc Compositions and methods for controlling nematodes
US20100331545A1 (en) 2007-10-24 2010-12-30 Nippon Chemiphar Co., Ltd. Regulator for signaling toll-like receptor, which comprises cathepsin inhibitor as active ingredient
EP2240491B1 (de) 2008-01-09 2015-07-15 Amura Therapeutics Limited TETRAHYDROFURO(2,3-b)PYRROL-3-ON DERIVATE ALS INHIBITOREN VON CYSTEIN PROTEINASEN
GB0804701D0 (en) 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
GB0817424D0 (en) 2008-09-24 2008-10-29 Medivir Ab Protease inhibitors
GB0916608D0 (en) 2009-09-22 2009-11-04 Angeletti P Ist Richerche Bio Therapeutic compounds
US10087190B1 (en) * 2017-04-24 2018-10-02 Purdue Research Foundation Lactones
US10995803B2 (en) 2018-12-04 2021-05-04 Means Industries, Inc. Electromagnetic system for controlling the operating mode of a non friction coupling assembly and coupling and magnetic control assembly having same
WO2022147694A1 (en) * 2021-01-06 2022-07-14 Beijing Erai Therapeutics Co., Ltd. Aminoheteroaryl compounds and uses thereof
EP4613273A1 (de) 2024-03-06 2025-09-10 Vetbiolix Behandlung von knochenschwund

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013079A1 (es) 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
GB0003111D0 (en) 2000-02-10 2000-03-29 Novartis Ag Organic compounds
IL155958A0 (en) * 2000-11-17 2003-12-23 Medivir Ab Cysteine protease inhibitors
WO2002057270A1 (en) * 2001-01-17 2002-07-25 Amura Therapeutics Limited Inhibitors of cruzipain and other cysteine proteases
JP2003183161A (ja) * 2001-12-21 2003-07-03 Kitasato Inst:The 骨粗鬆症の予防治療剤
JP2007513890A (ja) 2003-12-12 2007-05-31 メルク フロスト カナダ リミテツド カテプシンシステインプロテアーゼ阻害剤
US20080200975A1 (en) 2004-01-06 2008-08-21 Nicast Ltd. Vascular Prosthesis with Anastomotic Member
CA2552726A1 (en) 2004-01-08 2005-07-21 Merck Frosst Canada Ltd. Cathepsin cysteine protease inhibitors
AU2005203972B2 (en) 2004-01-08 2010-11-18 Medivir Ab Cysteine protease inhibitors
GB0513839D0 (en) 2005-07-07 2005-08-10 Medivir Ab Cysteine protease inhibitors
GB0614052D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds

Also Published As

Publication number Publication date
DE602005019971D1 (de) 2010-04-29
EP1701960A1 (de) 2006-09-20
AR047373A1 (es) 2006-01-18
WO2005066180A9 (en) 2008-09-25
EP1701960B1 (de) 2010-03-17
HK1096956A1 (en) 2007-06-15
JP2007517852A (ja) 2007-07-05
US20080234260A1 (en) 2008-09-25
AU2005203972B2 (en) 2010-11-18
AU2005203972A1 (en) 2005-07-21
ES2341869T3 (es) 2010-06-29
JP4787765B2 (ja) 2011-10-05
CA2552739A1 (en) 2005-07-21
US7915300B2 (en) 2011-03-29
TWI343384B (en) 2011-06-11
US20110112089A1 (en) 2011-05-12
TW200536847A (en) 2005-11-16
BRPI0506719A (pt) 2007-05-02
WO2005066180A1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
ATE461200T1 (de) Inhibitoren von cysteinprotease
ATE482214T1 (de) Aspartylproteasehemmer
ATE439835T1 (de) Heterozyklische aspartyl-proteasehemmer
ATE530554T1 (de) Serinprotease-hemmer
ATE478070T1 (de) Heterozyklische aspartyl-proteasehemmer
NO20044258L (no) Cystein proteaseinhibitor
EP1499336A4 (de) Proteasehemmer
PT1586571E (pt) Inibidores da dipeptidil-peptidase
DK1699455T3 (da) Heterocykliske aspartylproteasehæmmere
DK1924593T3 (da) HCV NS3-proteaseinhibitorer
ATE414693T1 (de) Neuartige cis-imidazoline
NO20076678L (no) Glutamataggrekanaseinhibitorer
DE602005012267D1 (de) N von geräten
DE602004018837D1 (de) Ptidase-iv-inhibitoren
DK1817276T3 (da) Cathepsin cysteine protease inhibitors
DE502005005919D1 (de) Alkoxysilanterminierte prepolymere
EP1750696B1 (de) Resistenzvermeidende inhibitoren für retrovirale proteasen
EP1732891A4 (de) Resistenzvermeidende inhibitoren für retrovirale proteasen
ATE453699T1 (de) Klebstoffe
DK2067854T3 (da) Kloningsvektorer
ATE545642T1 (de) Mmp-inhibitoren
DE602005000066D1 (de) Verdichter
DK1645632T3 (da) Alkalisk protease
DE602005002824T8 (de) Kompressor
DE602005007683D1 (de) Verdichter

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties